IP Library › Granted Patent US 11,298,325
Granted Patent B2
US 11,298,325 · App. 17/097,039 · Granted Apr 12, 2022

Pharmaceutical compositions of pimobendan

Inventor: Péter Laczay (Budapest, HU)
A61K9/5031A61K9/1641A61K9/2081A61K9/5015A61K9/5089A61K31/341A61K31/501A61K31/55A61K31/585A61K31/635A61K45/06A61K2300/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,298,325
App. No.
17/097,039
Granted
Apr 12, 2022
Kind
B2
Abstract

A method for the preparation of a composition includes dispersing particulate pimobendan in a molten carrier matrix to form particles coated with the carrier matrix, where the molten carrier matrix includes one or more pharmaceutically acceptable carriers selected from a polyglycolized glyceride, a polyethylene glycol, and combinations thereof, atomizing the dispersion of coated particles, and cooling and collecting the coated particles from the atomized dispersion.

Claims (17)

1. A method for the preparation of a composition, the process comprising:

dispersing particulate pimobendan in a molten carrier matrix to form particles coated with the carrier matrix, wherein the molten carrier matrix comprises one or more pharmaceutically acceptable carriers selected from the group consisting of a polyglycolized glyceride, a polyethylene glycol, and combinations thereof;

atomizing the dispersion of coated particles; and

cooling and collecting the coated particles from the atomized dispersion.

2. The method of claim 1 , wherein the particulate pimobendan has a mean particle size of less than 20 μm, the carrier matrix has a melting point from 40° C. to 80° C., and the dispersing is performed in a high shear mixer to obtain a homogenous suspension of the coated particles within the carrier matrix.

3. The method of claim 1 , wherein the carrier matrix comprises a polyglycolized glyceride.

4. The method of claim 1 , wherein the polyglycolized glyceride comprises a stearoyl macrogol-32 glyceride, a lauroyl macrogolglyceride or a stearoyl macrogolglyceride.

5. The method of claim 1 , wherein the polyethylene glycol has an average molecular weight of 1,500 to 20,000 g/mol, or an average molecular weight of 4,000 to 6,000 g/mol.

6. The method of claim 1 , wherein the polyethylene glycol comprises PEG 6000.

7. The method of claim 1 , wherein the atomizing the dispersion of coated particles is performed using an atomizer selected from the group consisting of a rotary atomizer, a pressure or pneumatic nozzle, a sonic nozzle, and combinations thereof.

8. The method of claim 1 , wherein the atomizing the dispersion of coated particles is performed using a two-fluid pressure or pneumatic nozzle atomization system fitted in a spray congealing/chilling apparatus and using atomizing gas pressures of 1 to 10 bar.

9. The method of claim 1 , wherein the cooling and collecting the coated particles from the atomized dispersion comprises applying a stream of cool air or an inert gas at a temperature of 0° to 30° C. from a spray apparatus to the coated particles within a cyclone separator or a bag filter.

10. The method of claim 9 , wherein the cool air or inert gas is applied at a temperature of 5° to 15° C., or at a temperature of 4° to 8° C.

11. The method of claim 1 , further comprising:

blending the cooled and collected coated particles with one or more additional components to form a blended mixture; and

compressing the blended mixture to form a tablet.

12. The method of claim 11 , wherein the one or more additional components comprises one or more additional active ingredients.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2021
From: LACZAY, PÉTER
To: BOEHRINGER INGELHEIM VETMEDICA GMBH
Reel/Frame 058586/0709 →
Priority Claims (1)
HU P1300702 · Dec 4, 2013 · national
Continuity (3)
Division 16193425 · Nov 16, 2018
Division 14558828 · Dec 3, 2014
Related Publication 20210059950A1 · Mar 4, 2021